EMA guidelines highlight changes to IMPs triggering notification to regulators
Regulatory NewsJoanne S. Eglovitch
Chemistry, Manufacturing and Controls (CMC)Clinical TrialsComplianceEuropePharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy